Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Twist Bioscience Corporation shares valued at $318,681 were sold by Green Paula on Sep 16. At $37.43 per share, Green Paula sold 8,514 shares. The insider’s holdings dropped to 14,199 shares worth approximately $0.48 million following the completion of this transaction.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Also, Banyai William sold 1,275 shares, netting a total of over 53,474 in proceeds. Following the sale of shares at $41.94 each, the insider now holds 256,779 shares.
Before that, THORBURN JAMES M had sold 9,000 shares from its account. In a trade valued at $436,635, the Chief Financial Officer traded Twist Bioscience Corporation shares for $48.51 each. Upon closing the transaction, the insider’s holdings decreased to 9,000 shares, worth approximately $1.31 million.
As of June 29, 2021, William Blair has initiated its “an Outperform” rating for TWST. Earlier on June 04, 2021, Goldman initiated its rating. Their recommendation was “a Neutral” for TWST stock.
Analyzing TWST’s Price Performance
On Thursday, Twist Bioscience Corporation [NASDAQ: TWST] plunged -7.53% to $33.64. The stock’s lowest price that day was $33.45, but it reached a high of $35.98 in the same session. During the last five days, there has been a drop of approximately -16.79%. Over the course of the year, Twist Bioscience Corporation shares have dropped approximately -56.53%. Shares of the company reached a 52-week high of $84.63 on 01/04/22 and a 52-week low of $25.07 on 06/14/22. A 50-day SMA is recorded $43.62, while a 200-day SMA reached $48.16. Nevertheless, trading volume fell to 1.05 million shares from 0.43 million shares the previous day.
Support And Resistance Levels for Twist Bioscience Corporation (TWST)
According to the 24-hour chart, there is a support level at 32.73, which, if violated, would cause prices to drop to 31.83. In the upper region, resistance lies at 35.26. The next price resistance is at 36.89. RSI (Relative Strength Index) is 35.09 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.55, which suggests the price will decrease in the coming days. Percent R is at 98.29%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is Twist Bioscience Corporation subject to short interest?
Stocks of Twist Bioscience Corporation saw a sharp rise in short interest on Jul 14, 2022 jumping by 0.4 million shares to 6.66 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 6.26 million shares. A jump of 6.01% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.07 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.07.
Which companies own the most shares of Twist Bioscience Corporation (TWST)?
According to ARK Investment Management LLC filings, the company currently owns 6,267,721 shares, which is about 11.12% of the total TWST shares outstanding. The investor’s shares have appreciated by 1,003,466 from its previous 13-F filing of 5264255.0 shares. With the completion of the buy transaction, The Vanguard Group, Inc.’s stake is now worth $192,670,362. BlackRock Fund Advisors acquire a 6.57% interest valued at $159.81 million while SSgA Funds Management, Inc. purchased a 1,335,779 stake. A total of -3,001,678 shares of Twist Bioscience Corporation were bought by Fidelity Management & Research Co during the quarter, and 1,048,947 were bought by William Blair Investment Manageme. In its current portfolio, Nikko Asset Management Americas, holds 2,677,170 shares valued at $107.41 million.
In terms of Twist Bioscience Corporation share price expectations, FactSet research, analysts set an average price target of $49.17 in the next 12 months, up nearly 37.44% from the previous closing price of $36.38. Analysts anticipate Twist Bioscience Corporation stock to reach $60.00 by 2022, with the lowest price target being $35.00. In spite of this, 8 analysts ranked Twist Bioscience Corporation stock as a Hold at the end of 2022. On April 12, 2021, Piper Sandler assigned a price target of “an Overweight” to the stock and initiated coverage with a $150.